Navigation Links
The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
Date:2/14/2008

WELLINGTON, Fla., Feb. 14 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) today announced that it has reported fourth quarter and year end financial results for the fiscal year ended October 31, 2007.

The Company reported a 4,700% increase in total revenues recorded from $95,253 in fiscal year 2006 to $4,565,140 in fiscal year 2007. Further, the Company reported a 5,044% increase in fourth quarter revenues from $2,049,004 in fiscal year 2007 as compared to $39,831 reported in same quarter for fiscal year 2006.

The number of healthcare providers affiliated with Quantum subsidiary Renaissance Health System of Florida, Inc. (http://www.RHSFL.com) increased 33 percent from fiscal year 2006. In October 2006, the Company had established relationships with 1,200 providers. In October of 2007, that number increased to 1,600 and further expanded to 1,800 in January of 2008.

Additionally, the Company reported a 871% increase in the enrolled patient base served by Renaissance from 981 at the close of fiscal year 2007 to 101 at the same time in fiscal year 2006.

The Company reported net losses of $11,260,100 for fiscal year 2007 as compared to $4,672,760 in fiscal year 2006, representing an increase of 141%. The per share loss was $6.55 for fiscal year 2007 as compared to $4.72 for fiscal year 2006. Much of the increase was directly attributed to $3,993,027 in additional costs associated with debt financing and a $1,930,354 increase in personnel costs aligned with Company expansion.

Noel J. Guillama, President and CEO of The Quantum Group commented, "Fiscal year 2007 was a landmark year for our Company. We achieved a significant number of the benchmarks we set for ourselves. The development of our services, people and technology was in line with what we set out to accomplish and deliver. Most notably, our Company laid the groundwork for the successful completion of our public offering in the first quarter of fiscal year 2008 (December 13, 2007). This achievement has given us the resources to build on the progress attained during our first year of operations. Our accomplishments are the result of the exceptional employees/equity owners that make up this Company."

Guillama continued, "As we look toward the future, we intend to be a leader of innovation and progress in consulting and outsourcing services for the healthcare industry in the state of Florida. I believe our people are the catalyst that will propel this Company to achieve the goals we now have before us in fiscal year 2008. We have set a high standard for ourselves to follow and we look forward to the challenges and opportunities ahead in 2008 with great determination and excitement."

About the Company

The Quantum Group, Inc. is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services that will be leveraged by leading-edge technology to the nation's largest and fastest growing industry- healthcare.

The Company is engaged in the development and execution of a series of innovative patent-pending technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of nearly 1,800 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

BPC Financial Marketing

John Baldissera

800.368.1217

Or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum light beams good for fast technology
2. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
3. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
4. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
5. Results promising for computational quantum chemical methods for drug development
6. The Quantum Group, Inc. Announces Separation of Units
7. Broad-based group of physicians calls for improvement in stroke treatment
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
10. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
11. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay Southerland ... version at the International Roofing Expo in Orlando, Florida on February 17-19. , ... advanced weather technology in the hands of consumers, roofing contractors, manufacturers and distributors,” ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency dental ... at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, dentist ... include:, , Avulsed or knocked-out teeth , Dislodged ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company ... of lupus and Sjogrens syndrome, today announced the ... in patients with systemic lupus erythematosus (SLE) with ... --> Data from a multicenter ... RSLV-132 in 32 subjects with SLE demonstrate the ...
(Date:2/10/2016)... NEW YORK , Feb. 10, 2016 ... clinical-stage biopharmaceutical company, announced today that it has filed ... Myeloid Leukemia and other cancers. --> ... of treating cancer by administration of Ceplene (histamine dihydrochloride) ... also provides methods of predicting the efficacy of Ceplene ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will ... Victoria Park Plaza in London , 24-25 ... and future advances for late phase research on Wednesday, 24 ... , associate director of project management at Worldwide, will focus ... regulations and standards in late phase research. ...
Breaking Medicine Technology: